PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.\', \'Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.\', \'Cluster of Excellence: Exzellenzcluster (EXC) 2124: Controlling Microbes to Fight Infection, Tübingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.798859
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34956236
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all